When Traditional Treatments Fail,
Ketamine Offers a New Path

What is PTSD?

Post-Traumatic Stress Disorder (PTSD) can develop after experiencing or witnessing traumatic events and may affect a person’s sense of safety, emotional regulation, relationships, and overall quality of life. Symptoms can include intrusive memories, flashbacks, nightmares, heightened anxiety, emotional numbness, irritability, difficulty sleeping, or feeling constantly “on edge.” For many individuals, trauma can remain deeply stored within both the mind and body, even after time has passed. Ketamine therapy is an emerging, research-supported treatment option that may help reduce the intensity of PTSD symptoms, improve emotional processing, and support healing when combined with comprehensive mental health care and trauma-informed support.

Understanding PTSD and How It May Overlap With Other Mental Health Conditions

Post-Traumatic Stress Disorder (PTSD) is a trauma-related condition that develops after experiencing or witnessing a deeply distressing or life-threatening event. Unlike anxiety or depression alone, PTSD is specifically connected to unresolved trauma and may involve symptoms such as flashbacks, nightmares, intrusive memories, emotional numbness, hypervigilance, exaggerated startle response, avoidance behaviors, and feeling constantly unsafe or “on edge.” Many individuals with PTSD also experience difficulty regulating emotions, maintaining relationships, or feeling connected to themselves and others.

PTSD can sometimes resemble or overlap with other mental health conditions because trauma affects both the nervous system and emotional health. For example, individuals with Generalized Anxiety Disorder (GAD) may experience chronic worry and tension, while PTSD-related anxiety is often linked to trauma triggers, fear responses, or nervous system hyperactivation. Social Anxiety may overlap when trauma creates fear of judgment, rejection, or emotional vulnerability around others. Mixed Anxiety and Depression commonly occurs alongside PTSD, as ongoing emotional distress, exhaustion, hopelessness, and nervous system dysregulation can contribute to both anxious and depressive symptoms.

PTSD may also coexist with Obsessive-Compulsive Disorder (OCD), particularly when intrusive thoughts, fear-based thinking, or compulsive behaviors develop as attempts to regain a sense of control or safety after trauma. In some cases, PTSD can also be mistaken for Major Depressive Disorder (MDD) or Treatment-Resistant Depression (TRD) because trauma survivors may experience emotional numbness, low motivation, isolation, fatigue, and persistent sadness. Additionally, periods of emotional dysregulation, agitation, impulsivity, or disrupted sleep in PTSD may occasionally resemble symptoms seen in Bipolar Disorder, making a thorough mental health evaluation important for accurate diagnosis and treatment planning.

Because these conditions frequently overlap, many individuals may experience more than one diagnosis at the same time. Understanding the root causes of symptoms — including the role of trauma, nervous system dysregulation, biology, and life experiences — can help guide a more personalized and effective treatment approach.

Ketamine (Intravenous Ketamine)

IV ketamine is administered directly into the bloodstream through an intravenous infusion, allowing for highly controlled dosing and rapid absorption. Because the medication bypasses digestion and enters circulation immediately, IV ketamine is considered the most bioavailable and precisely adjustable form of treatment. It is commonly used for Treatment-Resistant Depression (TRD), PTSD, anxiety disorders, chronic pain conditions, and acute suicidal ideation. IV infusions are often referenced in treatment plans as an “induction series” or “loading phase,” typically involving multiple sessions over several weeks followed by maintenance or booster infusions as needed.

How These Treatments May Be Referenced in a Treatment Plan

Ketamine treatment plans are often individualized and may include terms such as:

Induction Phase

Initial series of treatments designed to build symptom relief

Maintenance Therapy

Ongoing treatments intended to sustain progress

Booster Sessions

Periodic treatments provided when symptoms begin to return

Adjunctive Therapy

Ketamine used alongside psychotherapy, medications, lifestyle interventions, or wellness support

Integration Support

Therapeutic practices designed to help patients process emotional insights and reinforce long-term healing after treatment sessions

Because every patient responds differently, treatment frequency, dosing approach, and maintenance needs may vary over time based on symptom severity, diagnosis, overall health, and therapeutic goals.

Who May Not Be a Good Candidate for Ketamine?

Ketamine therapy for PTSD may not be appropriate for individuals whose trauma symptoms are currently so severe that dissociative experiences could become overwhelming or destabilizing without adequate therapeutic support. Patients with active psychosis, schizophrenia-spectrum disorders, uncontrolled substance use disorders, severe cardiovascular disease, uncontrolled hypertension, or certain neurological conditions may face increased risks during treatment. Because ketamine can temporarily create altered states of awareness, individuals with severe dissociation, poor emotional stabilization, or limited support systems may benefit from additional preparation, trauma-informed therapy, or stabilization work before pursuing treatment. A thorough psychiatric and medical evaluation can help determine whether ketamine therapy is an appropriate and safe component of a patient’s trauma recovery plan.

Important Considerations.

Hormonal imbalances, vitamin deficiencies, chronic inflammation, nervous system dysregulation, poor sleep, and other underlying health concerns can all influence the severity of PTSD symptoms and the effectiveness of ketamine therapy. Trauma often affects the body as well as the mind, contributing to disruptions in stress hormones such as cortisol and adrenaline, which may leave individuals feeling constantly overwhelmed, hypervigilant, emotionally exhausted, or disconnected. Deficiencies in nutrients such as vitamin D, B12, iron, magnesium, and folate may further contribute to fatigue, mood instability, anxiety, difficulty concentrating, and impaired nervous system function. Thyroid dysfunction, chronic pain, autoimmune conditions, substance use, and untreated sleep disorders may also impact emotional regulation and recovery. Addressing these underlying physical health factors alongside ketamine therapy can help support nervous system healing, improve resilience to stress, enhance emotional processing, and promote more sustainable long-term treatment outcomes.

How can you help your success?

Healing from PTSD is often most effective when ketamine therapy is combined with an active commitment to long-term emotional, physical, and nervous system support. Patients may contribute to their success by participating consistently in trauma-informed therapy, practicing healthy sleep habits, maintaining balanced nutrition, reducing substance use, engaging in regular movement or exercise, and developing stress regulation skills such as mindfulness, grounding exercises, breathwork, or meditation. Building supportive relationships, establishing routines, and allowing time for emotional processing and integration after treatment sessions can also help reinforce healing. 

Because PTSD symptoms may fluctuate during times of stress or life transitions, maintenance may include periodic booster treatments, ongoing psychotherapy, nervous system regulation practices, medication management when appropriate, and continued wellness support tailored to each individual’s recovery journey and long-term goals.

References Supporting Ketamine Therapy for PTSD

  1. Feder A, Parides MK, Murrough JW, et al. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Psychiatry. This landmark study demonstrated rapid and significant reduction in PTSD symptoms following ketamine infusion compared to control treatment. (PMC)
  2. Feder A, Costi S, Rutter SB, et al. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic PTSD. American Journal of Psychiatry. This study found that repeated ketamine infusions produced meaningful improvement in PTSD symptoms and depressive symptoms in individuals with chronic PTSD. (PMC)
  3. Albott CS, Lim KO, Forbes MK, et al. The Effects of Repeated Ketamine Infusions on PTSD Symptoms: Clinical Outcomes and Durability. Research demonstrated sustained symptom reduction following a series of ketamine treatments in treatment-resistant PTSD populations. (Sage Journals)
  4. Duek O, Li Y, Blackman MR, et al. Ketamine and Trauma-Related Disorders: A Systematic Review. This review summarized emerging evidence supporting ketamine’s rapid effects on trauma-related symptoms, emotional regulation, and suicidal ideation in PTSD patients. (PMC)
  5. Dandekar MP, Fenoy AJ, Carvalho AF, et al. Ketamine for Treatment-Resistant PTSD: Clinical Evidence and Future Directions. This review discussed ketamine’s effects on glutamate signaling, neuroplasticity, and fear extinction pathways associated with PTSD recovery. (ScienceDirect)
  6. Feder A, Costi S, Rutter SB, et al. Combining Ketamine Infusions With Exposure-Based Therapy for Chronic PTSD. Journal of Clinical Psychiatry. This open-label trial suggested that ketamine combined with trauma-focused psychotherapy may enhance long-term treatment outcomes. (PMC)
  7. Abdallah CG, Averill CL, Collins KA, et al. Ketamine Treatment and Neural Mechanisms in PTSD. Research explored ketamine’s role in improving neuroplasticity and reducing trauma-related hyperarousal and intrusive symptoms. (PMC)
  8. Whittaker E, Dadabayev AR, Joshi SA, Glue P. Ketamine in the Treatment of Refractory Anxiety Spectrum Disorders: Systematic Review and Meta-Analysis. This review included evidence supporting ketamine’s benefit in PTSD and related anxiety-spectrum conditions. (Sage Journals)
  9. ClinicalTrials.gov. Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD). Ongoing clinical research evaluating the safety, tolerability, and effectiveness of repeated ketamine infusions for PTSD symptom reduction. (ClinicalTrials.gov)
  10. Frontiers in Psychiatry. The Multivariate Effect of Ketamine on PTSD: Systematic Review and Meta-Analysis. This review evaluated available human studies examining ketamine’s effects on acute and chronic PTSD symptoms. (frontiersin.org)